Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|19|29|5297-5313
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.19, Iss.29, 2013-09, pp. : 5297-5313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Niacin ER combinations effective in lipid metabolism disorders
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Access to resources
Recommend
Antioxidant Therapy in Critically Septic Patients
Current Drug Targets, Vol. 10, Iss. 9, 2009-09 ,pp. :
Patients are less likely to receive lipid-lowering drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. :
Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism
Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. :